Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine

BACKGROUND: There are currently no serum biomarkers capable of distinguishing elevations in serum alanine aminotransferase (ALT) that portend serious liver injury potential from benign elevations such as those occurring during cholestyramine treatment. The aim of the research was to test the hypothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Singhal, Rohit, Harrill, Alison H, Menguy-Vacheron, Francoise, Jayyosi, Zaid, Benzerdjeb, Hadj, Watkins, Paul B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130124/
https://www.ncbi.nlm.nih.gov/pubmed/25086653
http://dx.doi.org/10.1186/2050-6511-15-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130124/
https://www.ncbi.nlm.nih.gov/pubmed/25086653
http://dx.doi.org/10.1186/2050-6511-15-42

Ejemplares similares